{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:59:02Z","timestamp":1790981942569,"version":"4.1.0"},"reference-count":146,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.biopha.2020.110835","type":"journal-article","created":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T18:29:56Z","timestamp":1602008996000},"page":"110835","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"special_numbering":"C","title":["ASBT(SLC10A2): A promising target for treatment of diseases and drug discovery"],"prefix":"10.1016","volume":"132","author":[{"given":"Na","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Qian","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Xiang","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Miao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-Ze","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen-Shen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2020.110835_bib0005","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3389\/fphar.2018.00931","article-title":"Ileal bile acid transporter inhibition for the treatment of chronic constipation, cholestatic pruritus, and NASH","volume":"9","author":"Samer","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.biopha.2020.110835_bib0010","first-page":"509","article-title":"An important intestinal transporter that regulates the enterohepatic circulation of bile acids and cholesterol homeostasis: The apical sodium-dependent bile acid transporter (SLC10A2\/ASBT)","volume":"41","author":"Xiao","year":"2017","journal-title":"Clin Res Hepatol Gas."},{"issue":"02","key":"10.1016\/j.biopha.2020.110835_bib0015","first-page":"189","article-title":"Advances in studies of ileal apical sodium-dependent bile acid transporter","volume":"52","author":"Ge","year":"2017","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.biopha.2020.110835_bib0020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/1389200216666150401110754","article-title":"PepT1, ASBT-Linked Prodrug Strategy to Improve Oral Bioavailability and Tissue Targeting Distribution","volume":"16","author":"Han","year":"2015","journal-title":"Curr. Drug Metab."},{"issue":"1","key":"10.1016\/j.biopha.2020.110835_bib0025","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/toxsci\/kfz088","article-title":"Experimental evidence of liver injury by BSEP-Inhibiting drugs with a bile salt supplementation in rats","volume":"170","author":"Yang","year":"2019","journal-title":"Toxicol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2020.110835_bib0030","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.apsb.2015.01.001","article-title":"Metabolic effects of intestinal absorption and enterohepatic cycling of bile acids","volume":"5","author":"Ferrebee","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"issue":"8","key":"10.1016\/j.biopha.2020.110835_bib0035","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1021\/acs.molpharmaceut.9b00426","article-title":"Tyrosine phosphorylation regulates plasma membrane expression and stability of the human bile acid transporter ASBT (SLC10A2)","volume":"16","author":"Chothe","year":"2019","journal-title":"Mol. Pharm."},{"issue":"5","key":"10.1016\/j.biopha.2020.110835_bib0040","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1080\/07420528.2018.1426596","article-title":"The influences of cholecystectomy on the circadian rhythms of bile acids as well as the enterohepatic transporters and enzymes systems in mice","volume":"35","author":"Zhang","year":"2018","journal-title":"Chronobiol. Int."},{"issue":"14","key":"10.1016\/j.biopha.2020.110835_bib0045","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1074\/jbc.RA119.011032","article-title":"S-Acylation modulates the function of the apical sodium-dependent bile acid transporter in human cells","volume":"295","author":"Ticho","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.biopha.2020.110835_bib0050","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1016\/j.jprot.2012.04.036","article-title":"MALDI-TOF mass spectrometry screening of cholelithiasis risk markers in the gene of HNF1alpha","volume":"75","author":"Richter","year":"2012","journal-title":"J. Proteomics"},{"issue":"4","key":"10.1016\/j.biopha.2020.110835_bib0055","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/86871","article-title":"Hepatocyte nuclear factor-1alpha is an essential regulator of bile acid and plasma cholesterol metabolism","volume":"27","author":"Shih","year":"2001","journal-title":"Nat. Genet."},{"issue":"9","key":"10.1016\/j.biopha.2020.110835_bib0060","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1136\/gut.2005.085555","article-title":"Cholesterol dependent downregulation of mouse and human apical sodium dependent bile acid transporter (ASBT) gene expression: molecular mechanism and physiological consequences","volume":"55","author":"Thomas","year":"2006","journal-title":"Gut."},{"issue":"1","key":"10.1016\/j.biopha.2020.110835_bib0065","doi-asserted-by":"crossref","first-page":"G123","DOI":"10.1152\/ajpgi.00102.2011","article-title":"Regulation of the gene encoding the intestinal bile acid transporter ASBT by the caudal-type homeobox proteins CDX1 and CDX2","volume":"302","author":"Ma","year":"2012","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"18","key":"10.1016\/j.biopha.2020.110835_bib0070","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.3748\/wjg.v19.i18.2736","article-title":"Relationships of CDXs and apical sodium-dependent bile acid transporter in Barrett\u2019s esophagus","volume":"19","author":"Zhao","year":"2013","journal-title":"World J. Gastroenterol."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2020.110835_bib0075","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jsbmb.2007.07.005","article-title":"Transactivation of the human apical sodium-dependent bile acid transporter gene by human serum","volume":"108","author":"Duane","year":"2008","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"42","key":"10.1016\/j.biopha.2020.110835_bib0080","doi-asserted-by":"crossref","first-page":"38703","DOI":"10.1074\/jbc.M104511200","article-title":"The role of AP-1 in the transcriptional regulation of the rat apical sodium-dependent bile acid transporter","volume":"276","author":"Chen","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.biopha.2020.110835_bib0085","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1053\/gast.2002.37055","article-title":"Inflammatory-mediated repression of the rat ileal sodium-dependent bile acid transporter by c-fos nuclear translocation","volume":"123","author":"Chen","year":"2002","journal-title":"Gastroenterology."},{"issue":"2","key":"10.1016\/j.biopha.2020.110835_bib0090","doi-asserted-by":"crossref","first-page":"G163","DOI":"10.1152\/ajpgi.00276.2013","article-title":"c-Fos mediates repression of the apical sodium-dependent bile acid transporter by fibroblast growth factor-19 in mice","volume":"306","author":"Ghosh","year":"2014","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110835_bib0095","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/hep.20295","article-title":"Bile acid-induced negative feedback regulation of the human ileal bile acid transporter","volume":"40","author":"Neimark","year":"2004","journal-title":"Hepatology."},{"issue":"1","key":"10.1016\/j.biopha.2020.110835_bib0100","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/bdd.694","article-title":"Effects of 1alpha, 25-dihydroxyvitamin D3 on transporters and enzymes of the rat intestine and kidney in vivo","volume":"31","author":"Chow","year":"2010","journal-title":"Biopharm. Drug Dispos."},{"issue":"6","key":"10.1016\/j.biopha.2020.110835_bib0105","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1124\/mol.105.020792","article-title":"Transactivation of rat apical sodium-dependent bile acid transporter and increased bile acid transport by 1alpha, 25-dihydroxyvitamin D3 via the vitamin D receptor","volume":"69","author":"Chen","year":"2006","journal-title":"Mol. Pharmacol."},{"issue":"34","key":"10.1016\/j.biopha.2020.110835_bib0110","doi-asserted-by":"crossref","first-page":"30559","DOI":"10.1074\/jbc.M203511200","article-title":"Human apical sodium-dependent bile salt transporter gene (SLC10A2) is regulated by the peroxisome proliferator-activated receptor alpha","volume":"277","author":"Jung","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.biopha.2020.110835_bib0115","doi-asserted-by":"crossref","first-page":"G675","DOI":"10.1152\/ajpgi.00176.2009","article-title":"Glucocorticoids differentially regulate Na-bile acid cotransport in normal and chronically inflamed rabbit ileal villus cells","volume":"298","author":"Jung","year":"2010","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110835_bib0120","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/gut.53.1.78","article-title":"Human ileal bile acid transporter gene ASBT (SLC10A2) is transactivated by the glucocorticoid receptor","volume":"53","author":"Jung","year":"2004","journal-title":"Gut."},{"issue":"7","key":"10.1016\/j.biopha.2020.110835_bib0125","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.dld.2016.03.022","article-title":"Glucocorticoid treatment alters systemic bile acid homeostasis by regulating the biosynthesis and transport of bile salts","volume":"48","author":"Xiao","year":"2016","journal-title":"Dig. Liver Dis."},{"issue":"2","key":"10.1016\/j.biopha.2020.110835_bib0130","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1124\/mol.58.2.361","article-title":"Dexamethasone induces pregnane X receptor and retinoid X receptor-alpha expression in human hepatocytes: synergistic increase of CYP3A4 induction by pregnane X receptor activators","volume":"58","author":"Pascussi","year":"2000","journal-title":"Mol. Pharmacol."},{"issue":"22","key":"10.1016\/j.biopha.2020.110835_bib0135","doi-asserted-by":"crossref","first-page":"19909","DOI":"10.1074\/jbc.M207903200","article-title":"Liver receptor homologue-1 mediates species- and cell line-specific bile acid-dependent negative feedback regulation of the apical sodium-dependent bile acid transporter","volume":"278","author":"Chen","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.biopha.2020.110835_bib0140","doi-asserted-by":"crossref","first-page":"G60","DOI":"10.1152\/ajpgi.00170.2004","article-title":"FXR-activating ligands inhibit rabbit ASBT expression via FXR-SHP-FTF cascade","volume":"288","author":"Chen","year":"2005","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"1\u20133","key":"10.1016\/j.biopha.2020.110835_bib0145","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bbaexp.2006.01.003","article-title":"FTF and LRH-1, two related but different transcription factors in human Caco-2 cells: their different roles in the regulation of bile acid transport","volume":"1732","author":"Pan","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"issue":"09","key":"10.1016\/j.biopha.2020.110835_bib0150","first-page":"1195","article-title":"Research progress of drugs for cholestasis targeting nuclear receptors","volume":"31","author":"Chen","year":"2015","journal-title":"Chinese Pharmacological Bulletin"},{"issue":"9","key":"10.1016\/j.biopha.2020.110835_bib0155","doi-asserted-by":"crossref","first-page":"G925","DOI":"10.1152\/ajpgi.00263.2011","article-title":"Nuclear factor-E2-related factor 2 is a major determinant of bile acid homeostasis in the liver and intestine","volume":"302","author":"Weerachayaphorn","year":"2012","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"4","key":"10.1016\/j.biopha.2020.110835_bib0160","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jcmgh.2018.01.006","article-title":"Organic solute transporter \u03b1-\u03b2 protects ileal enterocytes from bile acid-induced injury","volume":"5","author":"Ferrebee","year":"2018","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"7","key":"10.1016\/j.biopha.2020.110835_bib0165","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1136\/gut.2009.204990","article-title":"Conditional Gata4 deletion in mice induces bile acid absorption in the proximal small intestine","volume":"59","author":"Beuling","year":"2010","journal-title":"Gut."},{"issue":"201","key":"10.1016\/j.biopha.2020.110835_bib0170","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-3-642-14541-4_4","article-title":"Role of the intestinal bile acid transporters in bile acid and drug disposition","author":"Dawson","year":"2011","journal-title":"Handb. Exp. Pharmacol."},{"issue":"3","key":"10.1016\/j.biopha.2020.110835_bib0175","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jhep.2015.04.030","article-title":"Gut microbiota inhibit Asbt-dependent intestinal bile acid reabsorption via Gata4","volume":"63","author":"Out","year":"2015","journal-title":"J. Hepatol."},{"issue":"10","key":"10.1016\/j.biopha.2020.110835_bib0180","doi-asserted-by":"crossref","first-page":"G1216","DOI":"10.1152\/ajpgi.00017.2012","article-title":"Enteropathogenic Escherichia coli inhibits ileal sodium-dependent bile acid transporter ASBT","volume":"302","author":"Annaba","year":"2012","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"3","key":"10.1016\/j.biopha.2020.110835_bib0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229896","article-title":"Gender differences in diet-induced steatotic disease in Cyp2b-null mice","volume":"15","author":"Heintz","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biopha.2020.110835_bib0190","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/bmb\/ldaa006","article-title":"Obeticholic acid-a new therapy in PBC and NASH","volume":"133","author":"Chapman","year":"2020","journal-title":"Br. Med. Bull."},{"issue":"2","key":"10.1016\/j.biopha.2020.110835_bib0195","doi-asserted-by":"crossref","first-page":"152","DOI":"10.21037\/hbsn.2019.09.03","article-title":"Bile acid-based therapies for non-alcoholic steatohepatitis and alcoholic liver disease","volume":"9","author":"Li","year":"2020","journal-title":"Hepatobiliary Surg. Nutr."},{"issue":"3","key":"10.1016\/j.biopha.2020.110835_bib0200","doi-asserted-by":"crossref","first-page":"G554","DOI":"10.1152\/ajpgi.00223.2019","article-title":"Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy","volume":"318","author":"Chiang","year":"2020","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"7","key":"10.1016\/j.biopha.2020.110835_bib0205","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s41401-018-0195-3","article-title":"A novel ASBT inhibitor, IMB17-15, repressed nonalcoholic fatty liver disease development in high-fat diet-fed Syrian golden hamsters","volume":"40","author":"Ge","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"issue":"2","key":"10.1016\/j.biopha.2020.110835_bib0210","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s13105-018-0610-8","article-title":"The ileal FGF15\/19 to hepatic FGFR4 axis regulates liver regeneration after partial hepatectomy in mice","volume":"74","author":"Li","year":"2018","journal-title":"J. Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.biopha.2020.110835_bib0215","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1038\/s41467-019-12896-x","article-title":"Theabrownin from Pu-erh tea attenuates hypercholesterolemia via modulation of gut microbiota and bile acid metabolism","volume":"10","author":"Huang","year":"2019","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.biopha.2020.110835_bib0220","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/hep.30810","article-title":"Direct and indirect effects of fibroblast growth factor (FGF) 15 and FGF19 on liver fibrosis development","volume":"71","author":"Schumacher","year":"2020","journal-title":"Hepatology."},{"issue":"3","key":"10.1016\/j.biopha.2020.110835_bib0225","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/hep.25740","article-title":"Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice","volume":"56","author":"Kong","year":"2012","journal-title":"Hepatology."},{"issue":"1","key":"10.1016\/j.biopha.2020.110835_bib0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.apsb.2015.06.002","article-title":"Regulation of AMP-activated protein kinase by natural and synthetic activators","volume":"6","author":"Grahame","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"issue":"6","key":"10.1016\/j.biopha.2020.110835_bib0235","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1111\/jcmm.14293","article-title":"Aucubin inhibited lipid accumulation and oxidative stress via Nrf2\/HO-1 and AMPK signalling pathways","volume":"23","author":"Shen","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.biopha.2020.110835_bib0240","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3389\/fphar.2020.00216","article-title":"Hepatic proteomic changes and Sirt1\/AMPK signaling activation by oxymatrine treatment in rats with non-alcoholic steatosis","volume":"11","author":"Xu","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2020.110835_bib0245","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.3390\/ijms21062061","article-title":"PPARs as metabolic regulators in the liver: lessons from liver-specific PPAR-Null mice","volume":"21","author":"Wang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"357","key":"10.1016\/j.biopha.2020.110835_bib0250","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf4823","article-title":"Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet-fed mice","volume":"8","author":"Rao","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biopha.2020.110835_bib0255","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3389\/fmed.2020.00060","article-title":"Attenuation of the hepatoprotective effects of ileal apical sodium dependent bile acid transporter (ASBT) inhibition in choline-deficient L-Amino acid-defined (CDAA) diet-fed mice","volume":"7","author":"Rao","year":"2020","journal-title":"Front. Med. (Lausanne)"},{"issue":"6","key":"10.1016\/j.biopha.2020.110835_bib0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218459","article-title":"Apical sodium-dependent bile acid transporter inhibition with volixibat improves metabolic aspects and components of non-alcoholic steatohepatitis in Ldlr-\/-.LEiden mice","volume":"14","author":"Salic","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biopha.2020.110835_bib0265","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40360-018-0200-y","article-title":"A randomised, double-blind, placebo-controlled phase 1 study of the safety, tolerability and pharmacodynamics of volixibat in overweight and obese but otherwise healthy adults: implications for treatment of non-alcoholic steatohepatitis","volume":"19","author":"Palmer","year":"2018","journal-title":"BMC Pharmacol. Toxicol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110835_bib0270","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12929-018-0475-8","article-title":"Jaundice revisited: recent advances in the diagnosis and treatment of inherited cholestatic liver diseases","volume":"25","author":"Palmer","year":"2018","journal-title":"J. Biomed. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2020.110835_bib0275","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.clinre.2017.08.007","article-title":"An update on the physiopathology and therapeutic management of cholestatic pruritus in children","volume":"42","author":"Th\u00e9baut","year":"2018","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/j.biopha.2020.110835_bib0280","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fmed.2020.00117","article-title":"New therapeutic targets in autoimmune cholangiopathies","volume":"7","author":"Gerussi","year":"2020","journal-title":"Front Med (Lausanne)."},{"issue":"6","key":"10.1016\/j.biopha.2020.110835_bib0285","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1016\/S0002-9440(10)61177-7","article-title":"A mouse model of hepatocellular carcinoma: ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice","volume":"160","author":"Nicholes","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.biopha.2020.110835_bib0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107539","article-title":"Apical sodium-dependent bile acid transporter, drug target for bile acid related diseases and delivery target for prodrugs: current and future challenges","volume":"212","author":"Li","year":"2020","journal-title":"Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.biopha.2020.110835_bib0295","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1159\/000450988","article-title":"Apical sodium-dependent transporter inhibitors in primary biliary cholangitis and primary sclerosing cholangitis","volume":"35","author":"Hegade","year":"2017","journal-title":"Dig. Dis."},{"issue":"2","key":"10.1016\/j.biopha.2020.110835_bib0300","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/hep.27973","article-title":"Pharmacological inhibition of apical sodium-dependent bile acid transporter changes bile composition and blocks progression of sclerosing cholangitis in multidrug resistance 2 knockout mice","volume":"63","author":"Miethke","year":"2016","journal-title":"Hepatology."},{"key":"10.1016\/j.biopha.2020.110835_bib0305","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.5604\/01.3001.0010.5497","article-title":"Bile acids in Cholestasis and its treatment","volume":"16","author":"Miethke","year":"2017","journal-title":"Ann. Hepatol."},{"issue":"3","key":"10.1016\/j.biopha.2020.110835_bib0310","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jhep.2015.10.024","article-title":"Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis","volume":"64","author":"Baghdasaryan","year":"2016","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.biopha.2020.110835_bib0315","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/apt.13457","article-title":"The ileal bile acid transporter inhibitor A4250 decreases serum bile acids by interrupting the enterohepatic circulation","volume":"43","author":"Baghdasaryan","year":"2016","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.biopha.2020.110835_bib0320","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1038\/s41598-018-25214-0","article-title":"Pilot study with IBAT inhibitor A4250 for the treatment of cholestatic pruritus in primary biliary cholangitis","volume":"8","author":"Al-Dury","year":"2018","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2020.110835_bib0325","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1002\/hep.22431","article-title":"The membrane protein ATPase class I type 8B member 1 signals through protein kinase C zeta to activate the farnesoid X receptor","volume":"48","author":"Frankenberg","year":"2008","journal-title":"Hepatology."},{"key":"10.1016\/j.biopha.2020.110835_bib0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.112301","article-title":"BabaoDan cures hepatic encephalopathy by decreasing ammonia levels and alleviating inflammation in rats","volume":"249","author":"Lu","year":"2020","journal-title":"J. Ethnopharmacol."},{"issue":"4","key":"10.1016\/j.biopha.2020.110835_bib0335","first-page":"352","article-title":"The direct contribution of astrocytes and microglia to the pathogenesis of hepatic encephalopathy","volume":"7","author":"Jaeger","year":"2019","journal-title":"J. Clin. Transl. Hepatol."},{"key":"10.1016\/j.biopha.2020.110835_bib0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neures.2016.04.009","article-title":"Minimal hepatic encephalopathy: a review","volume":"111","author":"Nardone","year":"2016","journal-title":"Neurosci. Res."},{"issue":"3","key":"10.1016\/j.biopha.2020.110835_bib0345","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/SGA.0000000000000376","article-title":"Beyond Lactulose: Treatment Options for Hepatic Encephalopathy","volume":"42","author":"Said","year":"2019","journal-title":"Gastroenterol. Nurs."},{"issue":"1","key":"10.1016\/j.biopha.2020.110835_bib0350","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jceh.2018.04.011","article-title":"Bile acids in hepatic encephalopathy","volume":"9","author":"DeMorrow","year":"2019","journal-title":"J. Clin. Exp. Hepatol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110835_bib0355","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jcmgh.2018.04.004","article-title":"Aberrant brain bile acid signaling and cholesterol accumulation: a new look at mechanisms in hepatic encephalopathy","volume":"6","author":"Jayakumar","year":"2018","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2020.110835_bib0360","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ebiom.2018.10.030","article-title":"Dysregulated bile acid signaling contributes to the neurological impairment in murine models of acute and chronic liver failure","volume":"37","author":"Xie","year":"2018","journal-title":"EBioMedicine."},{"key":"10.1016\/j.biopha.2020.110835_bib0365","article-title":"Expert insights: The potential role of the gut microbiome-bile acid-brain axis in the development and progression of Alzheimer\u2019s disease and hepatic encephalopathy","author":"Jia","year":"2019","journal-title":"Med. Res. Rev."},{"issue":"2","key":"10.1016\/j.biopha.2020.110835_bib0370","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ajpath.2015.10.005","article-title":"Bile acid signaling is involved in the neurological decline in a murine model of acute liver failure","volume":"186","author":"McMillin","year":"2016","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.biopha.2020.110835_bib0375","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.jhep.2016.07.046","article-title":"Cerebrospinal fluid metabolomics highlights dysregulation of energy metabolism in overt hepatic encephalopathy","volume":"65","author":"Weiss","year":"2016","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.biopha.2020.110835_bib0380","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/jnc.13243","article-title":"TGR5 signaling reduces neuroinflammation during hepatic encephalopathy","volume":"135","author":"McMillin","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2020.110835_bib0385","doi-asserted-by":"crossref","DOI":"10.1093\/cercor\/bhaa062","article-title":"Ultrasound stimulation suppresses LPS-Induced proinflammatory responses by regulating NF-\u03baB and CREB activation in microglial cells","author":"Chang","year":"2020","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.biopha.2020.110835_bib0390","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3389\/fimmu.2020.00410","article-title":"Human intestinal mononuclear phagocytes in health and inflammatory bowel disease","volume":"11","author":"Ca\u00ebr","year":"2020","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.biopha.2020.110835_bib0395","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11894-020-00781-3","article-title":"Hepatotoxicty of agents used in the management of inflammatory bowel disease: a 2020 update","volume":"22","author":"Barnhill","year":"2020","journal-title":"Curr. Gastroenterol. Rep."},{"issue":"10","key":"10.1016\/j.biopha.2020.110835_bib0400","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.3390\/cells8101197","article-title":"Mechanism of dyslipidemia in Obesity-Unique regulation of ileal villus cell brush border membrane sodium-bile acid cotransport","volume":"8","author":"Sundaram","year":"2019","journal-title":"Cells."},{"key":"10.1016\/j.biopha.2020.110835_bib0405","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ejps.2017.03.012","article-title":"Irinotecan-induced bile acid malabsorption is associated with down-regulation of ileal Asbt (Slc10a2) in mice","volume":"102","author":"Shi","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"issue":"12","key":"10.1016\/j.biopha.2020.110835_bib0410","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1139\/cjpp-2018-0017","article-title":"Bile acid malabsorption is associated with diarrhea in acute phase of colitis","volume":"96","author":"Hou","year":"2018","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"9","key":"10.1016\/j.biopha.2020.110835_bib0415","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1124\/dmd.109.027367","article-title":"Changes in mRNA expression levels of solute carrier transporters in inflammatory bowel disease patients","volume":"37","author":"Wojtal","year":"2009","journal-title":"Drug Metab. Dispos."},{"issue":"9","key":"10.1016\/j.biopha.2020.110835_bib0420","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1124\/dmd.114.058065","article-title":"Inflammatory bowel disease alters intestinal bile acid transporter expression","volume":"42","author":"Jahnel","year":"2014","journal-title":"Drug Metab. Dispos."},{"issue":"6","key":"10.1016\/j.biopha.2020.110835_bib0425","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1111\/jvim.15332","article-title":"Comparison of intestinal expression of the apical sodium-dependent bile acid transporter between dogs with and without chronic inflammatory enteropathy","volume":"32","author":"Giaretta","year":"2018","journal-title":"J. Vet. Intern. Med."},{"issue":"9","key":"10.1016\/j.biopha.2020.110835_bib0430","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1124\/dmd.109.027367","article-title":"Changes in mRNA expression levels of solute carrier transporters in inflammatory bowel disease patients","volume":"37","author":"Wojtal","year":"2009","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.biopha.2020.110835_bib0435","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1053\/j.gastro.2006.05.002","article-title":"c-Fos is a critical mediator of inflammatory-mediated repression of the apical sodium-dependent bile acid transporter","volume":"131","author":"Neimark","year":"2006","journal-title":"Gastroenterology."},{"issue":"11","key":"10.1016\/j.biopha.2020.110835_bib0440","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1177\/1756283X17734809","article-title":"An update on prucalopride in the treatment of chronic constipation","volume":"10","author":"Omer","year":"2017","journal-title":"Therap. Adv. Gastroenterol."},{"issue":"10","key":"10.1016\/j.biopha.2020.110835_bib0445","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1080\/17474124.2018.1522248","article-title":"Elobixibat for the treatment of constipation","volume":"12","author":"Chedid","year":"2018","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2020.110835_bib0450","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12872-015-0070-9","article-title":"Specific inhibition of bile acid transport alters plasma lipids and GLP-1","volume":"15","author":"Rudling","year":"2015","journal-title":"BMC Cardiovasc. Disord."},{"issue":"8","key":"10.1016\/j.biopha.2020.110835_bib0455","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S2468-1253(18)30123-7","article-title":"Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial","volume":"3","author":"Nakajima","year":"2018","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"12","key":"10.1016\/j.biopha.2020.110835_bib0460","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1080\/14656566.2018.1508450","article-title":"Elobixibat, the first-in-class ileal bile acid transporter inhibitor, for the treatment of chronic idiopathic constipation","volume":"19","author":"Miner","year":"2018","journal-title":"Expert Opin. Pharmacother."},{"issue":"11","key":"10.1016\/j.biopha.2020.110835_bib0465","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S2468-1253(19)30246-8","article-title":"Efficacy of drugs in chronic idiopathic constipation: a systematic review and network meta-analysis","volume":"4","author":"Luthra","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"10","key":"10.1016\/j.biopha.2020.110835_bib0470","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.cgh.2013.04.029","article-title":"Methods for diagnosis of bile acid malabsorption in clinical practice","volume":"11","author":"Vijayvargiya","year":"2013","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.biopha.2020.110835_bib0475","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.apsb.2015.05.006","article-title":"Current developments in pharmacological therapeutics for chronic constipation","volume":"5","author":"Jiang","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"issue":"34","key":"10.1016\/j.biopha.2020.110835_bib0480","article-title":"Bile acid and chronic functional constipation","volume":"27","author":"Han","year":"2018","journal-title":"Modern Journal of Integrated Traditional Chinese and Western Medicine."},{"issue":"1","key":"10.1016\/j.biopha.2020.110835_bib0485","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/ajg.2011.378","article-title":"Altered bile acid pool using IBAT inhibitors for constipation: a potentially increased risk of malignancy","volume":"107","author":"Trivedi","year":"2012","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.biopha.2020.110835_bib0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117458","article-title":"New combination therapy of gliclazide and quercetin for protection against STZ-induced diabetic rats","volume":"247","author":"Abdelkader","year":"2020","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.biopha.2020.110835_bib0495","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s12291-017-0668-z","article-title":"A Narrative Review of Potential Future Antidiabetic Drugs: Should We Expect More?","volume":"33","author":"Chikara","year":"2018","journal-title":"Indian J. Clin. Biochem."},{"issue":"11","key":"10.1016\/j.biopha.2020.110835_bib0500","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1210\/en.2015-1321","article-title":"Bile acids trigger GLP-1 release predominantly by accessing basolaterally located g protein-coupled bile acid receptors","volume":"156","author":"Brighton","year":"2015","journal-title":"Endocrinology."},{"key":"10.1016\/j.biopha.2020.110835_bib0505","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2018.12.018","article-title":"Developments in bile salt based therapies: a critical overview","volume":"161","author":"Donkers","year":"2019","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110835_bib0510","doi-asserted-by":"crossref","first-page":"dgz025","DOI":"10.1210\/clinem\/dgz025","article-title":"Gluco-metabolic effects of pharmacotherapy-induced modulation of bile acid physiology","volume":"105","author":"Br\u00f8nden","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.biopha.2020.110835_bib0515","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2009.08.001","article-title":"TGR5-mediated bile acid sensing controls glucose homeostasis","volume":"10","author":"Br\u00f8nden","year":"2009","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.biopha.2020.110835_bib0520","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1124\/mol.116.103861","article-title":"Modulation of ionic channels and insulin secretion by drugs and hormones in pancreatic Beta cells","volume":"90","author":"Velasco","year":"2016","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.biopha.2020.110835_bib0525","doi-asserted-by":"crossref","first-page":"324","DOI":"10.2337\/db18-0315","article-title":"TGR5 activation promotes stimulus-secretion coupling of pancreatic \u03b2-Cells via a PKA-Dependent pathway","volume":"68","author":"Maczewsky","year":"2019","journal-title":"Diabetes."},{"issue":"3","key":"10.1016\/j.biopha.2020.110835_bib0530","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.metabol.2015.10.021","article-title":"The bile acid TUDCA increases glucose-induced insulin secretion via the cAMP\/PKA pathway in pancreatic beta cells","volume":"65","author":"Vettorazzi","year":"2016","journal-title":"Metab. Clin. Exp."},{"issue":"1","key":"10.1016\/j.biopha.2020.110835_bib0535","doi-asserted-by":"crossref","first-page":"E68","DOI":"10.1152\/ajpendo.00323.2011","article-title":"Inhibition of apical sodium-dependent bile acid transporter as a novel treatment for diabetes","volume":"302","author":"Chen","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.biopha.2020.110835_bib0540","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.1021\/jm400459m","article-title":"Discovery of a highly potent, nonabsorbable apical sodium-dependent bile acid transporter inhibitor (GSK2330672) for treatment of type 2 diabetes","volume":"56","author":"Wu","year":"2013","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2020.110835_bib0545","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000450983","article-title":"Bile acid uptake transporters as targets for therapy","volume":"35","author":"Slijepcevic","year":"2017","journal-title":"Dig. Dis."},{"issue":"7","key":"10.1016\/j.biopha.2020.110835_bib0550","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/dom.12656","article-title":"Glucose and lipid effects of the ileal apical sodium-dependent bile acid transporter inhibitor GSK2330672: double-blind randomized trials with type 2 diabetes subjects taking metformin","volume":"18","author":"Nunez","year":"2016","journal-title":"Diabetes Obes. Metab."},{"issue":"5","key":"10.1016\/j.biopha.2020.110835_bib0555","doi-asserted-by":"crossref","first-page":"G978","DOI":"10.1152\/ajpgi.00379.2004","article-title":"Cholesterol modulates human intestinal sodium-dependent bile acid transporter","volume":"288","author":"Alrefai","year":"2005","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"9","key":"10.1016\/j.biopha.2020.110835_bib0560","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1194\/jlr.M094607","article-title":"Efficient reabsorption of transintestinally excreted cholesterol is a strong determinant for cholesterol disposal in mice","volume":"60","author":"van de","year":"2019","journal-title":"J. Lipid Res."},{"issue":"36","key":"10.1016\/j.biopha.2020.110835_bib0565","doi-asserted-by":"crossref","first-page":"33920","DOI":"10.1074\/jbc.M306370200","article-title":"Targeted deletion of the ileal bile acid transporter eliminates enterohepatic cycling of bile acids in mice","volume":"278","author":"Dawson","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.biopha.2020.110835_bib0570","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/ptr.5295","article-title":"Hypolipidemic effect and mechanism of Palmatine from Coptis chinensis in hamsters fed high-fat diet","volume":"29","author":"Dawson","year":"2015","journal-title":"Phytother. Res."},{"issue":"8","key":"10.1016\/j.biopha.2020.110835_bib0575","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1021\/acs.bioconjchem.5b00230","article-title":"Design, Synthesis, and Therapeutic Evaluation of Poly(acrylic acid)-tetraDOCA Conjugate as a Bile Acid Transporter Inhibitor","volume":"26","author":"Park","year":"2015","journal-title":"Bioconjug. Chem."},{"issue":"14","key":"10.1016\/j.biopha.2020.110835_bib0580","first-page":"1611","article-title":"Advances in studies on apical sodium-dependent bile acid transporter and its inhibitors","volume":"21","author":"Liu","year":"2012","journal-title":"Chinese Journal of New Drugs."},{"issue":"5","key":"10.1016\/j.biopha.2020.110835_bib0585","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S0022-2275(20)39868-0","article-title":"Effects of 2164U90 on ileal bile acid absorption and serum cholesterol in rats and mice","volume":"36","author":"Lewis","year":"1995","journal-title":"J. Lipid Res."},{"issue":"50","key":"10.1016\/j.biopha.2020.110835_bib0590","doi-asserted-by":"crossref","first-page":"14916","DOI":"10.1021\/bi0205404","article-title":"Identification of a region of the ileal-type sodium\/bile acid cotransporter interacting with a competitive bile acid transport inhibitor","volume":"41","author":"Hall\u00e9n","year":"2002","journal-title":"Biochemistry."},{"issue":"8","key":"10.1016\/j.biopha.2020.110835_bib0595","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1194\/jlr.M200121-JLR200","article-title":"Ileal bile acid transporter inhibition, CYP7A1 induction, and antilipemic action of 264W94","volume":"43","author":"Root","year":"2002","journal-title":"J. Lipid Res."},{"issue":"4","key":"10.1016\/j.biopha.2020.110835_bib0600","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/hep.30908","article-title":"Lean NAFLD: a distinct entity shaped by differential metabolic adaptation","volume":"71","author":"Chen","year":"2020","journal-title":"Hepatology."},{"issue":"10","key":"10.1016\/j.biopha.2020.110835_bib0605","first-page":"772","article-title":"Research progress in potential therapeutic drugs for cholestatic liver diseases","volume":"42","author":"Ding","year":"2018","journal-title":"PPS."},{"issue":"5","key":"10.1016\/j.biopha.2020.110835_bib0610","doi-asserted-by":"crossref","DOI":"10.1111\/nmo.13571","article-title":"Efficacy, long-term safety, and impact on quality of life of elobixibat in more severe constipation: post hoc analyses of two phase 3 trials in Japan","volume":"31","author":"Nakajima","year":"2019","journal-title":"Neurogastroenterol. Motil."},{"issue":"1","key":"10.1016\/j.biopha.2020.110835_bib0615","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12876-020-1179-6","article-title":"Elobixibat alleviates chronic constipation in hemodialysis patients: a questionnaire-based study","volume":"20","author":"Kamei","year":"2020","journal-title":"BMC Gastroenterol."},{"issue":"3","key":"10.1016\/j.biopha.2020.110835_bib0620","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/hep4.1305","article-title":"A randomized, controlled, phase 2 study of Maralixibat in the treatment of itching associated with primary biliary cholangitis","volume":"3","author":"Mayo","year":"2019","journal-title":"Hepatol Commun."},{"issue":"10","key":"10.1016\/j.biopha.2020.110835_bib0625","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/hep4.1244","article-title":"Placebo-controlled randomized trial of an intestinal bile salt transport inhibitor for pruritus in alagille syndrome","volume":"2","author":"Shneider","year":"2018","journal-title":"Hepatol Commun."},{"issue":"1","key":"10.1016\/j.biopha.2020.110835_bib0630","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-3877","article-title":"A drug regimen for progressive familial cholestasis type 2","volume":"141","author":"Malatack","year":"2018","journal-title":"Pediatrics."},{"issue":"4","key":"10.1016\/j.biopha.2020.110835_bib0635","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00535-017-1383-5","article-title":"Determining an optimal clinical dose of elobixibat, a novel inhibitor of the ileal bile acid transporter, in Japanese patients with chronic constipation: a phase II, multicenter, double-blind, placebo-controlled randomized clinical trial","volume":"53","author":"Nakajima","year":"2018","journal-title":"J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110835_bib0640","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/cpdd.576","article-title":"Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Evaluations Following Single Oral Doses of GSK2330672 in Healthy Japanese Volunteers","volume":"8","author":"Ino","year":"2019","journal-title":"Clin. Pharmacol. Drug Dev."},{"issue":"5","key":"10.1016\/j.biopha.2020.110835_bib0645","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/liv.14069","article-title":"Autotaxin, bile acid profile and effect of ileal bile acid transporter inhibition in primary biliary cholangitis patients with pruritus","volume":"39","author":"Hegade","year":"2019","journal-title":"Liver Int."},{"issue":"12","key":"10.1016\/j.biopha.2020.110835_bib0650","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1016\/S0022-2275(20)32090-3","article-title":"Substrate specificity of the ileal and the hepatic Na(+)\/bile acid cotransporters of the rabbit. II. A reliable 3D QSAR pharmacophore model for the ileal Na(+)\/bile acid cotransporter","volume":"40","author":"Baringhaus","year":"1999","journal-title":"J. Lipid Res."},{"issue":"04","key":"10.1016\/j.biopha.2020.110835_bib0655","first-page":"305","article-title":"Design,synthesis,and evaluation of N-(3,5-difluorophenyl)-1-(alkoxyphenyl)-7-dimethylamino-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxamides as inhibitors of ASBT","volume":"13","author":"Zhao","year":"2018","journal-title":"Chin Med Biotechnol."},{"issue":"8","key":"10.1016\/j.biopha.2020.110835_bib0660","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1124\/dmd.108.020511","volume":"36","author":"Sakamoto","year":"2008","journal-title":"Drug Metab. Dispos."},{"issue":"5","key":"10.1016\/j.biopha.2020.110835_bib0665","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.bmcl.2003.12.063","article-title":"A novel class of apical sodium-dependent bile acid transporter inhibitors: the amphiphilic 4-oxo-1-phenyl-1,4-dihydroquinoline derivatives","volume":"14","author":"Kurata","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2020.110835_bib0670","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejphar.2006.04.005","article-title":"Novel non-systemic inhibitor of ileal apical Na+-dependent bile acid transporter reduces serum cholesterol levels in hamsters and monkeys","volume":"539","author":"Kitayama","year":"2006","journal-title":"Eur. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.biopha.2020.110835_bib0675","first-page":"837","article-title":"Effect of the dimeric bile acid analogue S0960, a specific inhibitor of the apical sodium-dependent bile salt transporter in the ileum, on the renal handling of taurocholate","volume":"53","author":"Schlattjan","year":"2003","journal-title":"Arzneimittelforschung."},{"issue":"9","key":"10.1016\/j.biopha.2020.110835_bib0680","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/0006-2952(90)90233-B","article-title":"Effects of novel bile salts on cholesterol metabolism in rats and guinea-pigs","volume":"40","author":"Fears","year":"1990","journal-title":"Biochem. Pharmacol."},{"issue":"06","key":"10.1016\/j.biopha.2020.110835_bib0685","first-page":"860","article-title":"Progress in regulation of drug transporters and metabolic enzymes by resveratrol","volume":"51","author":"Jia","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"issue":"2","key":"10.1016\/j.biopha.2020.110835_bib0690","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1042\/BJ20131428","article-title":"Resveratrol promotes degradation of the human bile acid transporter ASBT (SLC10A2)","volume":"459","author":"Chothe","year":"2014","journal-title":"Biochem. J."},{"issue":"1-3","key":"10.1016\/j.biopha.2020.110835_bib0695","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.ejphar.2013.06.036","article-title":"Ileal apical sodium-dependent bile acid transporter protein levels are down-regulated through ubiquitin-dependent protein degradation induced by bile acids","volume":"714","author":"Miyata","year":"2013","journal-title":"Eur. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2020.110835_bib0700","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11745-017-4258-x","article-title":"Pectin penta-oligogalacturonide suppresses intestinal bile acids absorption and downregulates the FXR-FGF15 Axis in high-cholesterol fed mice","volume":"52","author":"Zhu","year":"2017","journal-title":"Lipids."},{"key":"10.1016\/j.biopha.2020.110835_bib0705","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2015.11.017","article-title":"Epiberberine reduces serum cholesterol in diet-induced dyslipidemia Syrian golden hamsters via network pathways involving cholesterol metabolism","volume":"774","author":"Zou","year":"2016","journal-title":"Eur. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.biopha.2020.110835_bib0710","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.phymed.2014.05.002","article-title":"The antihypercholesterolemic effect of jatrorrhizine isolated from Rhizoma Coptidis","volume":"21","author":"Wu","year":"2014","journal-title":"Phytomedicine."},{"issue":"3","key":"10.1016\/j.biopha.2020.110835_bib0715","doi-asserted-by":"crossref","first-page":"G467","DOI":"10.1152\/ajpgi.00360.2009","article-title":"Green tea catechin EGCG inhibits ileal apical sodium bile acid transporter ASBT","volume":"298","author":"Annaba","year":"2010","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"4","key":"10.1016\/j.biopha.2020.110835_bib0720","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154305","article-title":"Grape seed procyanidins and cholestyramine differentially alter bile acid and cholesterol homeostatic gene expression in mouse intestine and liver","volume":"11","author":"Heidker","year":"2016","journal-title":"PLoS One"},{"issue":"03","key":"10.1016\/j.biopha.2020.110835_bib0725","first-page":"226","article-title":"Eliminating sputum and removing stasis formulation\u2019s inhibition of bile acid absorption by Caco-2 monolayer cells","volume":"21","author":"Su","year":"2019","journal-title":"Chin J Health Care Med."},{"issue":"1","key":"10.1016\/j.biopha.2020.110835_bib0730","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1038\/s41598-017-04536-5","article-title":"Herbal medicine Yinchenhaotang protects against \u03b1-naphthylisothiocyanate-induced cholestasis in rats","volume":"7","author":"Yan","year":"2017","journal-title":"Sci. Rep."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220310283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220310283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:58:28Z","timestamp":1760097508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332220310283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":146,"alternative-id":["S0753332220310283"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110835","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ASBT(SLC10A2): A promising target for treatment of diseases and drug discovery","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110835","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"110835"}}